Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression

Journal of Clinical Investigation(2020)10.1172/jci128313Source: DataRank Database

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 53 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access53 citations

Download PDF

Cite:

Linked data & code

bioproject doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 4.02)OA: bronzeTopics (61)Linked Datasets (10)DataCite Reuse (10)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (27)

Kalpit Shah ORCID,Sofia Gargani ORCID,Liyan Lao ORCID,Mansour Alsaleem ORCID,Jianing Chen ORCID

Live enrichment

PubMed:32125284 PMC:PMC7260014 OpenAlex:https://openalex.org/W3009698927

Action Against Cancer

Grant: G1661

Action Against Cancer

Grant: G1828

Intramural NIH HHS

Grant: Z01 ES101765

National Institute for Health Research (NIHR)

Grant: NIHR-RP-011-053

National Institutes of Health

Grant: 1Z01ES101765-05

Bioinformatics

FWCI

4.02

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: cc-by

journalhttp://www.jci.org/articles/view/128313/files/pdf

publisherhttp://www.jci.org/articles/view/128313/files/pdf

publisherhttps://www.jci.org/articles/view/128313/files/pdf

journalhttps://doi.org/10.1172/jci128313

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32125284

Fields of Study

Cell Adhesion Molecules ResearchHER2/EGFR in Cancer ResearchAngiogenesis and VEGF in Cancer0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AnimalsFemaleFibroblastsHumansMice, TransgenicNeoplasm InvasivenessNeoplasm MetastasisNeoplasm ProteinsNeoplasm TransplantationGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticMiceClass I Phosphatidylinositol 3-KinasesHeterograftsTriple Negative Breast Neoplasms

Keywords

Triple-negative breast cancerKinomeCancer researchTumor microenvironmentTumor progressionBiologyBreast cancerMetastasisCarcinogenesisParacrine signallingCancerKinaseReceptorCell biologyGeneticsTumor cellsSignal transductionProtein kinasesOncologyClass I Phosphatidylinositol 3-KinasesImmunology610Mice, TransgenicTriple Negative Breast NeoplasmsGene Expression Regulation, EnzymologicMiceAnimalsHumansNeoplasm InvasivenessNeoplasm Metastasis11 Medical and Health SciencesBreast cancer; Cell Biology; Oncology; Protein kinases; Signal transductionRFibroblastsR1Neoplasm ProteinsGene Expression Regulation, NeoplasticHeterograftsFemaleNeoplasm Transplantation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer

10.6084/m9.figshare.21382898.v1figshare

Additional file 1 of Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer

10.6084/m9.figshare.21382898figshare

Additional file 4 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645272.v1figshare

Additional file 4 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645272figshare

Additional file 3 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645269figshare

Additional file 1 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645263.v1figshare

Additional file 3 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645269.v1figshare

Additional file 2 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645266figshare

Additional file 2 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645266.v1figshare

Additional file 1 of Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer

10.6084/m9.figshare.26645263figshare

PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression

FAIR Checklist

Authors (27)

Funding (5 grants)

Impact

Open Access

Topics

Linked Datasets (10)

Annotations (Europe PMC)